A comparative evaluation of 162 inhalant users.
D000281:Administration, Intranasal; D000293:Adolescent; D002648:Child; D003072:Cognition Disorders; D003617:Dangerous Behavior; D004644:Emotions; D005260:Female; D006801:Humans; D013287:Illicit Drugs / Q000008:administration & dosage*; D007360:Intelligence; D008297:Male; D010554:Personality Disorders; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D012920:Social Behavior Disorders; D019966:Substance-Related Disorders / Q000523:psychology*
D013287:Illicit Drugs; D004364:Pharmaceutical Preparations